343
Participants
Start Date
March 31, 2005
Primary Completion Date
May 31, 2006
Study Completion Date
May 31, 2006
TAK-128
TAK-128 5 mg, tablets, orally, once daily for up to 6 months.
TAK-128
TAK-128 50 mg, tablets, orally, once daily for up to 6 months.
TAK-128
TAK-128 100 mg, tablets, orally, once daily for up to 6 months.
Placebo
TAK-128 placebo-matching tablets, orally, once daily for up to 6 months.
Mesa
Peoria
Phoenix
Tucson
Little Rock
Huntington Beach
La Jolla
Long Beach
Los Angeles
Northridge
San Francisco
Torrance
Tustin
Aventura
Fort Myers
Hialeah
Miami
Palm Beach Gardens
Plant City
Decatur
Chicago
Louisville
New Orleans
Boston
Ann Arbor
Flint
St Louis
Las Vegas
Elizabeth
New Brunswick
Buffalo
Staten Island
Greenville
Oklahoma City
Morrisville
Dallas
Houston
San Antonio
Norfolk
Tacoma
Calgary
Vancouver
Kingston
North Bay
Sarina
Gatineau
Laval
Québec
Lead Sponsor
Takeda
INDUSTRY